TR
Rhelion Life Sciences Corp.
TRUFF · OTC
$0.03 +8.23% (+$0.00)
1M +10.63%
Market Cap $13.6M
P/E Ratio -
Div. Yield -
ROE 43.00%
Piotroski F-Score Weak
2/9Valuation
71 /100
Cheap P/B 0.72x
P/S 4.40x
EV/EBITDA N/A
Growth
23 /100
Declining Book val. growth 22.86%
Rev. growth 2.03%
FCF growth N/A
Profitability
14 /100
Weak Net margin 213.37%
Op. margin 263.74%
FCF margin 129.94%
Quality
2 /100
Poor ROE 43.00%
ROA 30.04%
Asset turnover 0.14x
Debt
69 /100
Low Current ratio 3.25x
Int. coverage -97.77x
Debt/Equity 0.02x
Stability
47 /100
Moderate Rev. volatility 17.75%
EPS volatility 67.06%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TRUFF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Todd Michael Shapiro
Employees
104
Headquarters
Toronto
Prihajajoči dogodki
30 NOV.
Earnings
Upcoming earnings report